Post-emergence authorized share capital
Company: Core Scientific
The claim, verbatim
Under the proposed Third Amended and Restated Certificate of Incorporation, the company would be authorized to issue 12,000,000,000 shares: 10,000,000,000 common and 2,000,000,000 preferred, each with $0.00001 par value.
Source (primary)
core-scientific 8-K exhibit (d598371dex993.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-14)Live source ↗
Quote: “The total number of shares that the Corporation is authorized to issue is 12,000,000,000. Of such shares, 10,000,000,000, shall be shares of Common Stock”
How we checked this
Checked on November 16, 2026. The cited source supports every part of this claim.
Article IV.A of the proposed charter states each of these share counts and the $0.00001 par value for both classes.
Confirmed in the source:
- The proposed Third Amended and Restated Certificate of Incorporation authorizes 12,000,000,000 total shares
- 10,000,000,000 of the authorized shares are Common Stock
- 2,000,000,000 of the authorized shares are Preferred Stock
- Both the Common Stock and the Preferred Stock have a par value of $0.00001 per share
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524008952/d598371dex993.htm) in full (2,329,423 characters, retrieved November 14, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d598371dex993.htm)
Quote: “The total number of shares that the Corporation is authorized to issue is 12,000,000,000. Of such shares, 10,000,000,000, shall be shares of Common Stock”